Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Startling Healthcare Developments Revealed at Successful IDTechEx Healthcare Sensor Innovations 2019 Conference 2019-10-02 00:36
CapsCanada Expands Growth to New State-of-the-Art Facility 2019-10-01 19:00
Asia Derma returns to Singapore for second edition 2019-10-01 15:28
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations 2019-10-01 07:00
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval 2019-10-01 04:00
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability 2019-09-30 18:29
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
Ascletis Announces Departure of Chief Financial Officer 2019-09-30 16:30
First Digital Health Osteoarthritis Wearable Glove System Starts Pre-launch Pilot Trial Series & Medical Tests 2019-09-30 16:04
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis 2019-09-30 15:00
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019 2019-09-30 13:41
The 10th China (Taizhou) International Medical Expo successfully ended 2019-09-30 13:27
New Major Order From China 2019-09-30 11:45
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App 2019-09-30 09:00
Osteopore debuts on ASX, taking its unique 3D bone implant printing global 2019-09-30 09:00
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019 2019-09-30 06:00
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal 2019-09-30 05:00
Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer 2019-09-29 12:13
On World Heart Day, 29 September 2019, the World Heart Federation (WHF) Calls for Heart Health Equity Because Every Heartbeat Matters 2019-09-27 20:05
Simcere and JW Pharmaceutical Announce Collaboration and License Agreement for Anti-Gout Drug Candidate URC-102 in China 2019-09-27 18:52
1 619 620 621 622 623 962